Financial statements Advanced Biocomponents Poland
Balance sheet data of ADVANCED BIOCOMPONENTS POLAND
Year
|
2020
|
2021
|
2022
|
---|---|---|---|
Total assets | 589 968,43 | 1 102 030,77 | 987 867,02 |
A. Fixed assets | 13 144,31 | 7 705,31 | 31 534,61 |
B. Current assets | 576 824,12 | 1 094 325,46 | 956 332,41 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
Total liabilities | 589 968,43 | 1 102 030,77 | 987 867,02 |
A. Equity | 551 718,25 | 891 750,98 | 840 084,38 |
B. Liabilities and provisions for liabilities | 38 250,18 | 210 279,79 | 147 782,64 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 38 250,18 | 210 279,79 | 147 782,64 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.